enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Brolucizumab - Wikipedia

   en.wikipedia.org/wiki/Brolucizumab

   Brolucizumab is approved by the US Food and Drug Administration (FDA) for use in ophthalmology. [7] [8]Brolucizumab successfully completed phase III development in wet age-related macular degeneration (AMD) meeting the primary efficacy endpoint of non-inferiority to aflibercept in mean change in best corrected visual acuity (BCVA) from baseline to week 48.

3. List of drugs granted breakthrough therapy designation

   en.wikipedia.org/wiki/List_of_drugs_granted...

   Drug Manufacturer Indication Avacincaptad pegol: To treat geographic atrophy secondary to age-related macular degeneration [4] Cipaglucosidase alfa: To treat late-onset Pompe disease with miglustat [4] Dabrafenib: Dostarlimab: Eflornithine: Elranatamab: To treat relapsed or refractory multiple myeloma after at least four lines of therapy [4 ...

4. Ranibizumab - Wikipedia

   en.wikipedia.org/wiki/Ranibizumab

   Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab.It is an anti-angiogenic [16] that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.

5. Which Medications Are FDA-Approved for Weight Loss? - AOL

   www.aol.com/lifestyle/medications-fda-approved...

   There are seven FDA-approved weight loss medications currently available. These medications are safe and effective and have minimal side effects. Skip to main content. 24/7 Help. For premium ...

6. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

7. Aflibercept - Wikipedia

   en.wikipedia.org/wiki/Aflibercept

   In November 2011, the US Food and Drug Administration (FDA) approved aflibercept for the treatment of wet macular degeneration. [ 31 ] [ 32 ] In August 2012, the US FDA approved aflibercept (Zaltrap) for use in combination with 5-fluorouracil , folinic acid and irinotecan to treat adults with metastatic colorectal cancer that is resistant to ...

8. Weight-loss, diabetes drugs linked to vision problems in ...

   www.aol.com/weight-loss-diabetes-drugs-linked...

   Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were ...

9. Faricimab - Wikipedia

   en.wikipedia.org/wiki/Faricimab

   Faricimab, sold under the brand name Vabysmo (/ v ə ˈ b aɪ z m oʊ / və-BYEZ-mow), is a monoclonal antibody used for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).